Nephrocare Health Services Ltd (NHSL) will open its initial public offering (IPO) for subscription on Wednesday, December 10, with the issue remaining available until Friday, December 12.
The healthcare services provider aims to raise ₹871.05 crore, which includes a fresh issue of 0.77 crore shares worth ₹353.40 crore and an offer for sale of 1.13 crore shares totaling ₹517.64 crore.
The IPO allocation structure designates 75% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 10% for retail investors.
NHSL has set the price band at ₹438–₹460 per share, with a lot size of 32 shares, translating to a minimum retail investment of ₹14,720. The mainboard issue is set to be listed on both the NSE and BSE, with a tentative listing date of Wednesday, December 17.
